GRI977143
GRI977143 is a specific LPA2 receptor agonist, with an EC50 of 3.3 μM [1].
Product Specifications
CAS Number
325850-81-5
UNSPSC
12352005
Hazard Statement
H302, H372, H410
Target
Caspase; LPL Receptor
Type
Reference compound
Related Pathways
Apoptosis; GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/gri977143.html
Concentration
10mM
Purity
99.84
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(O)C1=CC=CC=C1SCCCN(C(C2=CC=CC3=CC=CC4=C23)=O)C4=O
Molecular Formula
C22H17NO4S
Molecular Weight
391.44
Precautions
H302, H372, H410
References & Citations
[1]Gyöngyi N. Kiss, et al. Virtual Screening for LPA2-Specific Agonists Identifies a Nonlipid Compound with Antiapoptotic Actions. Mol Pharmacol. 2012 Dec; 82 (6) : 1162–1173.|[2]Gyöngyi Nagyné Kiss, et al. PHARMACOLOGICAL AND CELLULAR CHARACTERIZATION OF GRI977143, A NOVEL NONLIPID LPA2 RECEPTOR AGONIST IDENTIFIED BY VIRTUAL SCREENING.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
LPAR2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740257-100 1x 100 µL
Cytokeratin, HMW (AE-3), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470043-100 1x 100 µL
P21 / WAF1 (WA-1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402175-500 1x 500 µL
Cytokeratin 8 (KRT8) (rB22.1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681074-100 1x 100 µL
SOX10 (SOX10/991 + SOX10/1074), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details